Flatworms Recall Familiar Environs, Even after Losing Their Heads: Scientific American

Flatworms Recall Familiar Environs, Even after Losing Their Heads: Scientific American.

Highly recommended reading. As it turns out, one does not have to go all the way down the evolutionary ladder to be reminded that even brain-impaired or brain-damaged individuals (whether through TBI, dementia, various levels of unconsciousness, or simply sleep) have not only memories, but continue to experience emotions, good and bad.

As an illustration that the brain is made of many different levels and parts, here is a recent paper by Feinstein et al. showing that individuals with a genetic absence of the amygdala, long highlighted as the brain’s influential “fear center”, can experience severe panic attacks.

They write:

 “A substantial body of evidence has emphasized the importance of the amygdala in fear […]. In animals, amygdala-restricted manipulations interfere with the acquisition, expression and recall of conditioned fear and other forms of fear and anxiety-related behaviors. In humans, focal bilateral amygdala lesions are extraordinarily rare, and such cases have been crucial for understanding the role of the human amygdala in fear. […] The most intensively studied case is patient SM, whose amygdala damage stems from Urbach-Wiethe disease […] Previous studies have shown that patient SM does not condition to aversive stimuli […], fails to recognize fearful faces […] and demonstrates a marked absence of fear during exposure to a variety of fear-provoking stimuli, including life-threatening traumatic events […]. Patients with similar lesions have largely yielded similar results […].

One stimulus not previously tested in humans with amygdala damage is CO2 inhalation. Inhaling CO2 stimulates breathing and can provoke both air hunger and fear […] Furthermore, CO2 can trigger panic attacks, especially in patients with panic disorder […]. Recent work in mice found that the amygdala directly detects CO2 and acidosis to produce fear behaviors […]. Thus, we hypothesized that bilateral amygdala lesions would reduce CO2-evoked fear in humans.

In contrast with our prediction, patient SM reported fear in response to a 35% CO2 inhalation challenge. To the best of our knowledge, this was the first time patient SM experienced fear in any setting, laboratory or otherwise, since childhood […]. To further explore this issue, we tested two additional patients (AM and BG), monozygotic twin sisters with focal bilateral amygdala lesions resulting from Urbach-Wiethe disease […] As with patient SM, both patients also reported experiencing fear during the CO2 challenge.” (Feinstein et al., 2013)

These startling observations affirm that the reaction to carbon dioxide (and probably, hypoxia as well) must be due to an alternative alarm system, such as has been proposed for possible suffocation (Maurice Preter and Donald F. Klein. Lifelong opioidergic vulnerability through early life separation: A recent extension of the false suffocation alarm theory of panic disorder. Submitted for publication).

Posted in Affective Neuroscience, Aging, development, epigenetics, Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, News, Psychiatry/Neurology | Tagged , , , , , , , , |

Metabolic Fate of Pharmaceuticals: A Focus on Slow Metabolizers

Very interesting and timely PowerPoint focusing on (now increasingly preventable) adverse outcomes, not on metabolism-related lack of efficacy.

>>It has been shown that variability in drug metabolism can have a substantial effect on clinical outcomes in patients. The impact of such variability in inter-individual responsiveness to the same dose of a given drug has historically received considerable attention. Drug metabolism is affected by numerous factors of both environmental and genetic origin. Recently, increased attention has been given to the genetic factors that may affect drug metabolism. A substantial portion of the population may have altered drug metabolism due to genetic factors that substantially affects their ability to metabolize specific drugs. These individuals are identified as slow metabolizers. Such individuals tend to accumulate substantially higher drug concentrations than normal metabolizers, which increases their risk for drug-related adverse events. It is important that clinicians consider the influence of slow metabolizer status when confronted with an adverse drug reaction. This slide set will discuss the issue of slow metabolizers, and will review several drugs that have been associated with slow metabolizer populations, including mephenytoin, hydralazine, isoniazid, and the newly marketed antihistamine, desloratadine.<<

The full slideshow is posted here:

mdnet_metabolic_v1.PDF – mdnet_metabolic_print.pdf.

Posted in epigenetics, Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, News | Tagged , , |

The Pros and Cons of Concierge Medical Care | NYCityWoman.com

The Pros and Cons of Concierge Medical Care | NYCityWoman.com

A thoughtful and balanced, and (yes) enthusiastic discussion of what it means to have a personal physician in U.S.A. anno 2013. Written by Sally Wendkos Olds, happy patient of Margaret Lewin, MD, a member of IDNY.

The full text is here: The Pros and Cons of Concierge Medical Care | NYCityWoman.com.

Well worth your reading time.

 

Posted in Aging, China, Events, Fifth Avenue Concierge Medicine, Health, keto, News | Tagged |

Simvastatin impairs exercise training adaptations.

Simvastatin impairs exercise training adaptations.

Mikus CR, et al. Show all

J Am Coll Cardiol. 2013 Aug 20;62(8):709-14. doi: 10.1016/j.jacc.2013.02.074. Epub 2013 Apr 10.

Affiliation

Division of Cardiology, Duke University Medical Center, Durham, North Carolina.

Abstract

OBJECTIVES: This study sought to determine if simvastatin impairs exercise training adaptations.

BACKGROUND: Statins are commonly prescribed in combination with therapeutic lifestyle changes, including exercise, to reduce cardiovascular disease risk in patients with metabolic syndrome. Statin use has been linked to skeletal muscle myopathy and impaired mitochondrial function, but it is unclear whether statin use alters adaptations to exercise training.

METHODS: This study examined the effects of simvastatin on changes in cardiorespiratory fitness and skeletal muscle mitochondrial content in response to aerobic exercise training. Sedentary overweight or obese adults with at least 2 metabolic syndrome risk factors (defined according to National Cholesterol Education Panel Adult Treatment Panel III criteria) were randomized to 12 weeks of aerobic exercise training or to exercise in combination with simvastatin (40 mg/day). The primary outcomes were cardiorespiratory fitness and skeletal muscle (vastus lateralis) mitochondrial content (citrate synthase enzyme activity).

RESULTS: Thirty-seven participants (exercise plus statins: n = 18; exercise only: n = 19) completed the study. Cardiorespiratory fitness increased by 10% (p < 0.05) in response to exercise training alone, but was blunted by the addition of simvastatin resulting in only a 1.5% increase (p < 0.005 for group by time interaction). Similarly, skeletal muscle citrate synthase activity increased by 13% in the exercise-only group (p < 0.05), but decreased by 4.5% in the simvastatin-plus-exercise group (p < 0.05 for group-by-time interaction).

CONCLUSIONS: Simvastatin attenuates increases in cardiorespiratory fitness and skeletal muscle mitochondrial content when combined with exercise training in overweight or obese patients at risk of the metabolic syndrome. (Exercise, Statins, and the Metabolic Syndrome; NCT01700530).

Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

PMID

23583255 [PubMed – in process]

PMCID

PMC3745788 [Available on 2014/8/20]

Full text: Elsevier Science

via Simvastatin impairs exercise training a – PubMed Mobile.

Posted in Complementary - Alternative Medicine, Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, metabolic | Tagged , , |

Among well-functioning older adults, DM and poor glucose control among those with DM are associated with worse cognitive function and greater decline. This suggests that severity of DM may contribute to accelerated cognitive aging.

Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia.

Yaffe K, et al. Show all

Arch Neurol. 2012 Sep;69(9):1170-5. doi: 10.1001/archneurol.2012.1117.

Affiliation

Departments of Psychiatry, University of California, San Francisco, and San Francisco, VA, USA. kristine.yaffe@ucsf.edu

Abstract

OBJECTIVES: To determine if prevalent and incident diabetes mellitus (DM) increase risk of cognitive decline and if, among elderly adults with DM, poor glucose control is related to worse cognitive performance. DESIGN Prospective cohort study.

SETTING: Health, Aging, and Body Composition Study at 2 community clinics.

PARTICIPANTS: A total of 3069 elderly adults (mean age, 74.2 years; 42% black; 52% female).

MAIN OUTCOME MEASURES: Participants completed the Modified Mini-Mental State Examination (3MS) and Digit Symbol Substitution Test (DSST) at baseline and selected intervals over 10 years. Diabetes mellitus status was determined at baseline and during follow-up visits. Glycosylated hemoglobin A1c level was measured at years 1 (baseline), 4, 6, and 10 from fasting whole blood.

RESULTS: At baseline, 717 participants (23.4%) had prevalent DM and 2352 (76.6%) were without DM, 159 of whom developed incident DM during follow-up. Participants with prevalent DM had lower baseline test scores than participants without DM (3MS: 88.8 vs 90.9; DSST: 32.5 vs 36.3, respectively; t = 6.09; P = .001 for both tests). Results from mixed-effects models showed a similar pattern for 9-year decline (3MS: -6.0- vs -4.5-point decline; t = 2.66; P = .008; DSST: -7.9- vs -5.7-point decline; t = 3.69; P = .001, respectively). Participants with incident DM tended to have baseline and 9-year decline scores between the other 2 groups but were not statistically different from the group without DM. Multivariate adjustment for demographics and medical comorbidities produced similar results. Among participants with prevalent DM, glycosylated hemoglobin A1c level was associated with lower average mean cognitive scores (3MS: F = 8.2; P for overall = .003; DSST: F = 3.4; P for overall = .04), even after multivariate adjustment.

CONCLUSION: Among well-functioning older adults, DM and poor glucose control among those with DM are associated with worse cognitive function and greater decline. This suggests that severity of DM may contribute to accelerated cognitive aging.

PMID

22710333 [PubMed – indexed for MEDLINE]

via Diabetes, glucose control, and 9-year c – PubMed Mobile.

Posted in Aging, epigenetics, Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, metabolic, Psychiatry/Neurology | Tagged , , , |